BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol. 2017;178:403-412. [PMID: 28382648 DOI: 10.1111/bjh.14672] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Andersen MJ Jr, Kerr DA, Lisovsky M, Vaickus LJ, Linos K. Fine needle aspiration of an intranodal follicular dendritic cell sarcoma: A case report with molecular analysis and review of the literature. Diagn Cytopathol 2021;49:E65-70. [PMID: 32816379 DOI: 10.1002/dc.24584] [Reference Citation Analysis]
2 Kim HM, Yang WI, Lyu CJ, Hahn SM, Yoon SO. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience. Yonsei Med J 2020;61:774-9. [PMID: 32882761 DOI: 10.3349/ymj.2020.61.9.774] [Reference Citation Analysis]
3 van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KS, Fössa A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Chadburn A, Fajgenbaum DC. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 2020;4:6039-50. [PMID: 33284946 DOI: 10.1182/bloodadvances.2020003334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Simpson D. Epidemiology of Castleman Disease. Hematol Oncol Clin North Am. 2018;32:1-10. [PMID: 29157611 DOI: 10.1016/j.hoc.2017.09.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
5 Chen HM, Shen YL, Liu M. Primary hepatic follicular dendritic cell sarcoma: A case report. World J Clin Cases 2019; 7(6): 785-791 [PMID: 30968045 DOI: 10.12998/wjcc.v7.i6.785] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Jiang C, Syed YA, Burdette EB, Jaye DL, Flowers CR, Khan MK. Retroperitoneal Follicular Dendritic Cell Sarcoma: A Case Report. Adv Radiat Oncol 2020;5:297-300. [PMID: 32280831 DOI: 10.1016/j.adro.2019.12.001] [Reference Citation Analysis]
7 Chezar K, Yilmaz A, Auer I, Trpkov K. Primary Follicular Dendritic Cell Sarcoma of Urinary Bladder. Int J Surg Pathol 2021;:1066896920981622. [PMID: 34323104 DOI: 10.1177/1066896920981622] [Reference Citation Analysis]
8 Ren W, Sun Q, Wu PY, Huang B, Yang J, Yan J, Liu BR. Profiles of genomic alterations in primary esophageal follicular dendritic cell sarcoma: A case report. Medicine (Baltimore) 2018;97:e13413. [PMID: 30508944 DOI: 10.1097/MD.0000000000013413] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
9 Asiry S, Khader SN, Villanueva-Siles E, Hakima L. Follicular dendritic cell sarcoma: Cytomorphologic features and diagnostic challenges. Diagn Cytopathol 2021;49:457-61. [PMID: 33418601 DOI: 10.1002/dc.24691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Oshiro H, Tome Y, Kiyuna T, Miyake K, Kawaguchi K, Higuchi T, Miyake M, Zang Z, Razmjooei S, Barangi M, Wangsiricharoen S, Nelson SD, Li Y, Bouvet M, Singh SR, Kanaya F, Hoffman RM. Temozolomide targets and arrests a doxorubicin-resistant follicular dendritic-cell sarcoma patient-derived orthotopic xenograft mouse model. Tissue Cell 2019;58:17-23. [PMID: 31133242 DOI: 10.1016/j.tice.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Shimono J, Miyoshi H, Arakawa F, Sato K, Furuta T, Muto R, Yanagida E, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Ohshima K. Prognostic factors for histiocytic and dendritic cell neoplasms. Oncotarget 2017;8:98723-32. [PMID: 29228722 DOI: 10.18632/oncotarget.21920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
12 Negre Busó M, Balliu Collgrós E, Ferran Sureda N, Velasco Nuño M, Roncero Vidal JM, Rubió Rodríguez A. Follicular dendritic cell tumor in the context of a Castleman disease in a patient with Diffuse Large B Cell Lymphoma: Diagnosis and follow-up with 18F-FDG PET/CT. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:322-4. [PMID: 34425975 DOI: 10.1016/j.remnie.2020.08.003] [Reference Citation Analysis]
13 Esmati E, Kolahdouzan K. Metastatic follicular dendritic cell sarcoma treated with gemcitabine plus docetaxel with an outstanding survival: A case report and review of literature. Clin Case Rep 2021;9:473-6. [PMID: 33489199 DOI: 10.1002/ccr3.3560] [Reference Citation Analysis]
14 Mao S, Dong J, Wang Y, Zhang C, Dong A, Shen J. Follicular Dendritic Cell Sarcomas: CT and MRI Findings in 20 Patients. AJR Am J Roentgenol 2021;216:835-43. [PMID: 33405946 DOI: 10.2214/AJR.19.22759] [Reference Citation Analysis]
15 Cheng JL, Cui J, Wang Y, Xu ZZ, Liu F, Liang SB, Tian H. Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature. World J Gastroenterol 2018; 24(34): 3958-3964 [PMID: 30228787 DOI: 10.3748/wjg.v24.i34.3958] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
16 Wu H, Liu P, Xie XR, Chi JS, Li H, Xu CX. Inflammatory pseudotumor-like follicular dendritic cell sarcoma: Literature review of 67 cases. World J Meta-Anal 2021; 9(1): 1-11 [DOI: 10.13105/wjma.v9.i1.1] [Reference Citation Analysis]
17 Li X, Shi Z, You R, Li Y, Cao D, Lin R, Huang X. Inflammatory Pseudotumor-Like Follicular Dendritic Cell Sarcoma of the Spleen: Computed Tomography Imaging Characteristics in 5 Patients. J Comput Assist Tomogr. 2018;42:399-404. [PMID: 29287022 DOI: 10.1097/rct.0000000000000700] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li HL, Liu HP, Guo GWJ, Chen ZH, Zhou FQ, Liu P, Liu JB, Wan R, Mao ZQ. Imaging findings of inflammatory pseudotumor-like follicular dendritic cell tumors of the liver: Two case reports and literature review. World J Gastroenterol 2019; 25(45): 6693-6703 [PMID: 31832007 DOI: 10.3748/wjg.v25.i45.6693] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Lei Y, Zhao S, Jiang M. Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review. Front Immunol 2021;12:653319. [PMID: 34566950 DOI: 10.3389/fimmu.2021.653319] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Xia R, Shafizadeh N, Brandler T, Liu C, Oweity T. Follicular dendritic cell sarcoma of the cervical lymph node diagnosed on fine needle aspiration cytology. Cytopathology 2021. [PMID: 34351024 DOI: 10.1111/cyt.13047] [Reference Citation Analysis]
21 Rogerson T, Trochsler M, Miliauskas J, Maddern G. First case report of Epstein-Barr virus-positive inflammatory pseudotumour-like follicular dendritic cell sarcoma in Australia. ANZ J Surg 2021;91:E157-8. [PMID: 32786020 DOI: 10.1111/ans.16216] [Reference Citation Analysis]
22 Carboni F, Covello R, Bertini L, Valle M. Uncommon retroperitoneal tumour: follicular dendritic cell sarcoma. Acta Chir Belg 2021;121:219-21. [PMID: 31690245 DOI: 10.1080/00015458.2019.1689646] [Reference Citation Analysis]
23 Massoth LR, Hung YP, Ferry JA, Hasserjian RP, Nardi V, Nielsen GP, Sadigh S, Venkataraman V, Selig M, Friedmann AM, Samore W, Killian JK, Milante R, Giessinger J, Foley-Peres K, Marcus C, Severson E, Duncan D, Sivakumar S, Ross JS, Desphande V, Ramkissoon SH, Vergilio JA, Louissaint A, Zukerberg LR, Williams EA. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. Oncologist 2021;26:e1263-72. [PMID: 33904632 DOI: 10.1002/onco.13801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]